XKON/336040 (XKON/336040)

Korea New Exchange: XKON/336040 · KRW

₩4,000

+100.00 (+2.6%)· Recorded snapshot

Market cap	22.9B
Revenue (ttm)	5.5B
Net income (ttm)	-1.7B
EPS (ttm)	-₩824
Shares out	5.7M
Volume	45
Beta	0.65

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 5.5B
Net income (ttm): -1.7B
EPS (ttm): -₩824
Market cap: 22.9B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-28 19:55 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-57.9

P25 n/aP50 n/aP75 n/a

ROIC-28.4

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All XKON/336040 indicators

Market & fundamental data

Available fields

148

Groups with data

Currency

KRW

Showing 148 of 148 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	KRW
Country	South Korea
Country code	KR
Exchange	Korea New Exchange
Financial currency	KRW
Financial report date	2019-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	2014
Industry	Surgical and Medical Instruments and Apparatus
Is primary listing	Yes
ISIN number	KR7336040001
Last refreshed	2026-10-28
Market cap	KRW 22.9B
Price	KRW 4,000.00
Price currency	KRW
SIC code	3841
Stock price date	2026-10-27
Symbol	xkon/336040
Website	https://www.yidobio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-20.6%
FCF yield	-6.92%
P/B ratio	6.89x
P/S ratio	4.13x
Price / tangible book value	10.59x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-31.58%
EBITDA margin	-21.88%
Gross margin	2.87%
Operating margin	-31.58%
Pretax margin	-31.47%
Profit margin	-31.47%
ROA	-17.75%
ROCE	-47.3%
ROE	-57.9%
ROIC	-28.38%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Revenue growth	84.97%
Revenue growth (QoQ)	0%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	KRW -232.1M
Depreciation and amortization	KRW 537.1M
EBIT	KRW -1.7B
EBITDA	KRW -1.2B
EPS	KRW -824.00
FCF per share	KRW -276.66
Financing cash flow	KRW 1.7B
Free cash flow	KRW -1.6B
Gross profit	KRW 158.9M
Investing cash flow	KRW -882.3M
Net borrowing	KRW -615.3M
Net cash flow	KRW -492.2M
Net income	KRW -1.7B
Operating income	KRW -1.7B
Revenue	KRW 5.5B

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-0.7
Book value per share	KRW 1,429.67
Debt / equity	0.17
Goodwill	KRW 741.8M
Interest coverage	-31.7
Long-term assets	KRW 2.1B
Long-term liabilities	KRW 83.9M
Net cash (debt)	KRW 332.9M
Net cash / market cap	1.46%
Net debt / equity	-0.1
Piotroski F-Score	1
Property, plant and equipment	KRW 524.5M
Shareholders' equity	KRW 3.3B
Tangible book value	KRW 2.2B
Tangible book value per share	KRW 1,021.02
Total assets	KRW 7.5B
Total cash	KRW 886.5M
Total debt	KRW 553.6M
Total liabilities	KRW 4.2B
WACC	7.83%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.9
Current assets	KRW 5.4B
Current liabilities	KRW 4.1B
Current ratio	1.52
Inventory turnover	5.28
Net working capital	KRW 1.4B
Quick ratio	1.01
Working capital	KRW 2B

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	KRW 3,593.07
1D price change	2.56%
1M price change	2.63%
1M total return	2.63%
1Y price change	-9.3%
1Y return CAGR	-9.31%
1Y total return	-9.3%
20-day SMA	KRW 3,905.00
200-day SMA	KRW 3,605.23
3M price change	50%
3M total return	50%
3Y price change	-54.39%
3Y return CAGR	-23.02%
3Y total return	-54.39%
50-day SMA	KRW 3,791.80
50-day SMA vs 200-day SMA	50over200
52-week high	KRW 5,280.00
52-week high date	2025-11-05
52-week low	KRW 1,800.00
52-week low date	2026-07-31
5Y price change	-83.72%
5Y return CAGR	-30.44%
5Y total return	-83.72%
6M price change	-4.88%
6M total return	-4.88%
All-time high	KRW 31,000.00
All-time high date	2021-07-08
All-time low	KRW 1,800.00
All-time low date	2026-07-31
Average true range (ATR)	KRW 181.59
Average volume	26.4
Beta (1Y)	-0.11
Beta (2Y)	0.09
Beta (5Y)	0.65
Change from 52-week high	-24.24%
Change from 52-week low	122.22%
Change from all-time high	-87.42%
Change from all-time low	116.67%
Change from open	5.26%
Day's gap	-2.56%
Dollar volume	KRW 180,000
High price	KRW 4,000.00
Low price	KRW 3,800.00
Monthly RSI	46.03
Open price	KRW 3,800.00
Position in 52-week range	100%
Previous close	KRW 3,900.00
Price vs 150-day SMA	8.54%
Price vs 20-day SMA	-0.13%
Price vs 200-day SMA	8.18%
Price vs 50-day SMA	2.85%
Relative volume	1.71
RSI	57.52
Sharpe ratio	0.71
Sharpe ratio (3Y)	-0.11
Sharpe ratio (5Y)	-0.25
Sortino ratio	1.12
Sortino ratio (3Y)	-0.09
Sortino ratio (5Y)	-0.27
Volume	45
Weekly RSI	54.58
YTD price change	30.22%
YTD total return	30.22%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1.4M
Shares change (QoQ)	0%
Shares held by insiders	40.62%
Shares held by institutions	35.64%
Shares outstanding	5.7M

Deeper analysis on XKON/336040

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this XKON/336040 report

Is a complete XKON/336040 research report available?

No complete published report is available for xkon/336040 (XKON/336040) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

XKON/336040 (XKON/336040)

Price

Financial snapshot

Fair-value bridge

Latest news · XKON/336040

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XKON/336040 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Performance and technicals

Ownership and float

Deeper analysis on XKON/336040

Frequently asked questions